Oftalone, Inc – Trademark Portfolio

Entity Type: 03

Oftalone, Inc holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include ONE, EUSOL-C, KERASAVE, and OFTALONE. The owner is based in Coral Gables, FL.

250 Catalonia Ave 506

Coral Gables, FL 33134

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

EUSOL-C
EUSOL-C
Registered 2022
ONE
ONE
Registered 2022
KERASAVE
KERASAVE
Registered 2022
OFTALONE
OFTALONE
Registered 2022

Trademark Classifications

Oftalone, Inc's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Oftalone, Inc have?

Oftalone, Inc has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does Oftalone, Inc file in?

Oftalone, Inc files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.

What are Oftalone, Inc's most well-known trademarks?

Oftalone, Inc's registered trademark portfolio includes well-known marks such as ONE, EUSOL-C, KERASAVE, and OFTALONE. These are among 4 currently registered trademarks in the portfolio.

What is Oftalone, Inc's trademark registration success rate?

Oftalone, Inc has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.